NeuBase Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

NeuBase Therapeutics

14/05/2021 19:49

* NeuBase Therapeutics Inc  NBSE.OQ  reported a quarterly
adjusted loss of 24 cents​​ per share for the quarter ended
in March. The mean expectation of four analysts for the quarter
was for a loss of 22 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* NeuBase Therapeutics Inc's reported EPS for the quarter was a
loss of 24 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* NeuBase Therapeutics Inc shares had fallen by 37.2% this
quarter and lost 33.6% so far this year.
* The company reported a quarterly loss of $5.52 million.
* Wall Street's median 12-month price target for NeuBase
Therapeutics Inc is $16.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 14 at 06:49 p.m. GMT.
​All figures in US dollars